<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Alterity Therapeutics Limited

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Alterity Therapeutics Limited

    We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases. Alterity Therapeutics was incorporated in Melbourne, Australia in 1997 as Prana Biotechnology and has offices in Melbourne, Australia, and San Francisco, USA. The Company listed on the Australian Securities Exchange in 2000 and listed on the NASDAQ in 2002. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Geoffrey Kempler
    • FOUNDED
      1997
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    HealthStream, Inc.

    HealthStream, Inc.

    HealthStream (NASDAQ: HSTM) is dedicated to improving patient outcomes through the...

    HealthStream (NASDAQ: HSTM) is dedicated to imp...

    Filing Type:    PU
    Second Sight Medical Products, Inc.

    Second Sight Medical Products, Inc.

    The recognized global leader in neuromodulation devices to treat blindness, the co...

    The recognized global leader in neuromodulation...

    Filing Type:    PU
    ACS Global, Inc.

    ACS Global, Inc.

    ACS Global, Inc. engages in the collection, processing, and long-term storage of s...

    ACS Global, Inc. engages in the collection, pro...

    Amount Raised:    $3,200,000
    Fundraising Status:    VT
    Filing Type:    PU
    Ascendis Pharma A/S

    Ascendis Pharma A/S

    Ascendis Pharma is applying its innovative technology platform to build a leading,...

    Ascendis Pharma is applying its innovative tech...

    Filing Type:    PU
    WinSanTor, Inc.

    WinSanTor, Inc.

    WinSanTor’s mission is simple-develop a drug that works. We recognize that there...

    WinSanTor’s mission is simple-develop a drug ...

    Amount Raised:    $572,649.00
    Fundraising Status:    EC
    Filing Type:    CF
    Amphastar Pharmaceuticals, Inc.

    Amphastar Pharmaceuticals, Inc.

    Amphastar Pharmaceuticals, Inc., headquartered in Rancho Cucamonga, California, es...

    Amphastar Pharmaceuticals, Inc., headquartered ...

    Filing Type:    PU
    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, le...

    Intra-Cellular Therapies is a biopharmaceutical...

    Filing Type:    PU
    Neurotrope, Inc.

    Neurotrope, Inc.

    Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its ana...

    Neurotrope is a clinical-stage biotech company ...

    Filing Type:    PU
    Brainstorm Cell Therapeutics Inc.

    Brainstorm Cell Therapeutics Inc.

    BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autolog...

    BrainStorm (NASDAQ:BCLI) is a biotechnology com...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.